Prolactin response to neuroleptics. Clinical and theoretical implications.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D010259:Paranoid Disorders / Q000188:drug therapy; D011388:Prolactin / Q000097:blood*; D012737:Sex Factors; D013881:Thioridazine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced
D014150:Antipsychotic Agents; D011388:Prolactin; D013881:Thioridazine